StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-4.64%)

Close on Nov 18, 2026Market cap $1.53MP/E –Yield –

Vivos Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vivos Therapeutics's market cap was $1.32M on Nov 11, 2026, against $18.68M a year earlier. Over the last 5 years it ranged from $1.32M to $76.86M, with a median of $14.04M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.32M-92.2%
2025Dec 31, 2025$16.78M-17.9%
2024Dec 31, 2024$20.44M+37.3%
2023Dec 29, 2023$14.89M+61.0%
2022Dec 30, 2022$9.25M-82.1%
2021Dec 31, 2021$51.78M-29.6%
2020Dec 31, 2020$73.55M–

More Vivos Therapeutics figures

See a number that looks wrong?